investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

HSC Diversity, in aging, ontogeny, and transformation

Irving L. Weissman

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Irving L. Weissman

Stanford University

Stanford, United States

Related projects

Thomas Waldmann

IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

Leukaemia

Pathology Hematology and hematologic malignancies

Clark W Distelhorst

Targeting PKM2-InsP3R interaction to treat AML

Leukaemia

Hematology and hematologic malignancies

Catherine Ju-Ying Wu

The role of the SF3B1 splicing factor in chronic lymphocytic leukemia

Leukaemia

Marc Nicklaus

In Silico Screening for Cancer Targets

Leukaemia

Pathology Hematology and hematologic malignancies

Ann Mullally

Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells

Leukaemia

David H Haussler

Center for Big Data in Translational Genomics

Leukaemia

Birgit Knoechel

Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia

Leukaemia

Vinay Pathak

Retroviral Replication and Interactions with Host Factors

Leukaemia

Pathology Hematology and hematologic malignancies

Marina Y Konopleva

Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia

Leukaemia